Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Fintech Innovation ETF (ARKF) vs Novo Nordisk A/S (NVO) Price & Performance

ARK Fintech Innovation ETFTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

ARK Fintech Innovation ETF vs Novo Nordisk A/S — how do they compare? ARK Fintech Innovation ETF trades at $42.86, while Novo Nordisk A/S trades at $46.02 (market cap $207.85B). The key difference: Novo Nordisk A/S pays a 3.81% dividend while ARK Fintech Innovation ETF pays none. Which is the better fit depends on your goals.

ARKFNVO
Sector
Sector/ThematicHealth
52-Week High
$58.82$63.98
52-Week Low
$36.14$35.29
Market Cap
$207.85B
Enterprise Value
$222.55B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Fintech Innovation ETF

ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.

Read more on ARKF

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO